ACTINIUM PHARMACEUTICALS
Actinium Pharmaceuticals provides biopharmaceutical, radiotherapies, medical research, development, and clinical trial services.
ACTINIUM PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Diagnostics Pharmaceutical
Founded:
2000-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.actiniumpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
BioSciences Research Associates
BioSciences Research Associates provides laboratory services for product development and clinical trials to pharmaceutical companies.
Canam Bioresearch
Canam Bioresearch is a biotechnology pharmaceutical company located in Winnipeg.
Clinical Research Associates
Clinical Research Associates is a research firm that provides research and clinical trials services.
ClinSmart
ClinSmart is a clinical research organization that specializes in drug safety, regulatory, medical trials, and biostatistics services.
IBEX Preclinical Research
IBEX Preclinical Research provides neurosurgical modeling, soft tissue surgery, drug development, and pre-clinical research services.
Seattle Allergy & Asthma Research Institute
Seattle Allergy & Asthma Research Institute researches allergies and asthma and helps pharmaceutical companies in medicinal developments.
Spear Products
Spear Products is a providers of biological raw materials for research, pharmaceutical, and medical manufacturing companies.
Waife & Associates
Waife & Associates focuses on pharmaceutical, medical, biostatics, clinical research and drug development services.
Current Employees Featured
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Actinium Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-02 | Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spearhead Iomab-B Commercialization |
Official Site Inspections
http://www.actiniumpharma.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.22 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Actinium Pharmaceuticals"
Management Team :: Actinium Pharmaceuticals, Inc. (ATNM)
Jenny has nearly two decades of experience in leading and developing corporate strategies across the healthcare and life sciences industries. Prior to joining Actinium, Jenny was the …See details»
Board of Directors :: Actinium Pharmaceuticals, Inc. (ATNM)
Jeffrey W. Chell, M.D. Director . Jeffrey W. Chell, M.D., became the National Marrow Donor Program's Chief Executive Officer in 2000 where he led the NMDP through transformational …See details»
Profile :: Actinium Pharmaceuticals, Inc. (ATNM)
Address: 100 Park Avenue 23rd Floor New York, NY 10017 . Telephone: (646) 677-3875. Email: [email protected]See details»
Actinium Pharmaceuticals - Crunchbase Company …
Organization. Actinium Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Actinium Expands Clinical Leadership Team to Support Key …
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, …See details»
Actinium Pharmaceuticals Selects Medpace Inc. as Clinical …
Actinium Pharmaceuticals, Inc. (www.actiniumpharma.com) is a New York-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for …See details»
Actinium Pharmaceuticals, Inc. – (ATNM)
Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies The Pivotal Phase 3 SIERRA Trial for Iomab-B is 100% Enrolled.See details»
Actinium Pharmaceuticals Inc - Company Profile - GlobalData
Website www.actiniumpharma.com Telephone 1 646 6773870. No of Employees 49. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange ATNM (AFM) Revenue (2023) …See details»
Actinium Pharmaceuticals, Inc. | LinkedIn
Ir.actiniumpharma.com 29 Like Comment Share Actinium Pharmaceuticals, Inc. 13,551 followers 1w Report this post Actinium Launches Clinical Program to Test Actimab-A With PD-1 Inhibitors in Solid ...See details»
Actinium Pharmaceuticals (ATNM) Company Profile & Description
Mar 24, 2025 100 Park Avenue, 23rd Floor New York, New York 10017 United StatesSee details»
About :: Actinium Pharmaceuticals, Inc. (ATNM)
Robust Pipeline. Actinium Pharmaceuticals' drug development pipeline features Iomab-B with positive pivotal Phase 3 results, Iomab-ACT, which is intended to be a conditioning regimen …See details»
Actinium Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Actinium Pharmaceuticals contact info: Phone number: (646) 677-3870 Website: www.actiniumpharma.com What does Actinium Pharmaceuticals do? Actinium …See details»
Investor Relations :: Actinium Pharmaceuticals, Inc. (ATNM)
Transfer Agent Securities Transfer Corporation 2901 N. Dallas Parkway Suite 380 Plano, Texas 75093 T: (469) 633-0101 F: (469) 633-0088 www.stctransfer.comSee details»
Actinium Pharmaceuticals - Craft
Oct 29, 2024 Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers. Its targeted radiotherapy …See details»
Actinium Pharmaceuticals - Contacts, Employees, Board Members, …
Actinium Pharmaceuticals provides biopharmaceutical, radiotherapies, medical research, development, and clinical trial services.See details»
Working at Actinium Pharmaceuticals - Zippia
Mar 14, 2024 www.actiniumpharma.com. Organization Type. Public. CEO. Sandesh Seth. Social Media. Actinium Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing …See details»
Actinium Pharmaceuticals Appoints Accomplished Biopharma …
Nov 4, 2024 She was a Vice President in the Clinical Safety Organization, chaired a PhRMA-FDA working group, and worked in the area of scientific licensing. She also led the …See details»
Actinium Announces Multiple Senior Leadership Appointments …
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies …See details»
Actinium Pharmaceuticals Announces Research Collaboration with …
Mar 20, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today...See details»
Actinium Pharmaceuticals Announces Supply Agreement with …
NEW YORK, March 24, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted …See details»